The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...

Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

Shares of Philip Morris International edged 0.4% higher in premarket action on Thursday to $120.80 vs. the 52-week range of $87.82 to $134.15. The dividend yield for new buyers of the stock is 4. ...

Philip Morris outperformed the S&P 500 in 2024 ... opinion and is not meant to be a recommendation of the purchase or sale of stock. The investments and strategies discussed within this article ...

The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant ...

Arrow's asset sale comes on the heels of similar restructuring moves ... Three of the new directors, James Dawsey, Kristine Duffy and Philip Morris, had served on the boards of Arrow's subsidiary ...